Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.

Breast cancer research and treatment - 1 Apr 2016

Vetter Lisa, Keller Monika, Bruckner Thomas, Golatta Michael, Eismann Sabine, Evers Christina, Dikow Nicola, Sohn Christof, Heil Jörg, Schott Sarah

Abstract excerpt

Breast cancer (BC) is the leading cancer among women worldwide and in 5-10 % of cases is of hereditary origin, mainly due to BRCA1/2 mutations. Therefore, the German Consortium for Familial Breast and Ovarian Cancer (HBOC) with its 15 specialized academic centers offers families at high risk for familial/hereditary cancer a multimodal breast cancer surveillance program (MBCS) with regular breast MRI, mammography,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Germany

Share to Ovarian Neoplasms

Share to Patient Compliance

Share to Population Surveillance

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 26960712
DOI: 10.1007/s10549-016-3748-5

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.PMID 26960712Read ↗

Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter Program.Semantic proximity Read ↗

[Genetic predisposition to breast and ovarian cancer: importance of test results].Semantic proximity Read ↗

Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.Semantic proximity Read ↗

Uptake of Screening and Risk Reducing Recommendations Among Women with Hereditary Breast and Ovarian Cancer Syndrome Evaluated at a Large Urban Comprehensive Cancer CenterSemantic proximity Read ↗

Risk-reducing mastectomy perceptions and decision-making among women at high risk of breast cancerSemantic proximity Read ↗

Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.Semantic proximity Read ↗

Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factorsSemantic proximity Read ↗

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.Semantic proximity Read ↗

The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.Semantic proximity Read ↗

Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.Semantic proximity Read ↗

Medical knowledge and information needs among women with pathogenic variants in moderate-risk genes for hereditary breast cancer attending genetic counseling at an academic hospital in Germany-A qualitative approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.